Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report.
about
Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature.Molecular changes associated with the development of resistance to imatinib in an imatinib-sensitive canine neoplastic mast cell line carrying a KIT c.1523A>T mutation.
P2860
Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Role of imatinib in the treatm ...... c mastocytosis: a case report.
@en
Role of imatinib in the treatm ...... c mastocytosis: a case report.
@nl
type
label
Role of imatinib in the treatm ...... c mastocytosis: a case report.
@en
Role of imatinib in the treatm ...... c mastocytosis: a case report.
@nl
prefLabel
Role of imatinib in the treatm ...... c mastocytosis: a case report.
@en
Role of imatinib in the treatm ...... c mastocytosis: a case report.
@nl
P2093
P2860
P1476
Role of imatinib in the treatm ...... c mastocytosis: a case report.
@en
P2093
Manoj Kumar Agarwala
Meera Thomas
Poonkuzhali Balasubramanian
Renu George
Sheila Nair
Vikram Mathews
P2860
P304
P356
10.3109/09546634.2013.802274
P577
2013-05-30T00:00:00Z